<- Back

Managing Atherogenic Dyslipidaemia QI Program

  • : Melbourne VIC 3000
QI Program Aim

While cardiovascular disease is widely understood to be one of Australia's largest health issues, atherogenic dyslipidaemia - a lipid abnormality associated with increased CVD risk - is currently under-managed in general practice. This QI (Quality Improvement) Program aims to optimise pharmacological and non-pharmacological management of lipid abnormalities in patients with atherogenic dyslipidaemia, to achieve a reduction in cardiovascular disease risk in patients.

Why take part in this QI program?

Inclusion Criteria

How long should it take?

Steps to Proceed

Content partners: 

Mylan

Category: 

Chronic conditions

Components
Managing Atherogenic Dyslipidaemia QI Program - Pre-test
Managing Atherogenic Dyslipidaemia QI Program - Declaration
Managing Atherogenic Dyslipidaemia QI Program - Patient Entry
Managing Atherogenic Dyslipidaemia QI Program - Results and Evaluation
Title
Managing Atherogenic Dyslipidaemia QI Program
Speciality Classification
Interest Areas / Topics Covered
-- GENERAL --
Location
Type
Delivery
Provider Type
RTO
CPD
RACGP 40 CPD, ACRRM 30 CME PD
Price
0.00
Location
Melbourne VIC 3000
Posted By
Contact Phone
Log in into view this field.
24 Views
Similar Courses and Events
HealthcareLink